Summary
Storms Pharma is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.0m and a net result of €249,362. Equity is growing by ~21.3% per year across the filed fiscal years. Its solvency ranks better than 49% of 5558 sector peers (fiscal year 2025). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
28 d early
2024
30 d early
2023
20 d early
2022
25 d early
2021
6 d early
2020
15 d early
2019
31 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 13 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€1.0m▲ 32.0%
2024 · €778,197
Net result
€249,362▲ 35.9%
2024 · €183,555
Total assets
€2.0m▲ 0.2%
2024 · €2.0m
Solvency
50.6%▲ 12.2pp
2024 · 38.4%
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€57,473▼ 26.6%€56,007▼ 2.6%€61,826▲ 10.4%€60,442▼ 2.2%€75,627▲ 25.1%
Net result€117,585▼ 56.2%€204,173▲ 73.6%€174,146▼ 14.7%€183,555▲ 5.4%€249,362▲ 35.9%
Equity€480,053▲ 26.8%€669,227▲ 39.4%€823,373▲ 23.0%€778,197▼ 5.5%€1.0m▲ 32.0%
Total assets€2.0m▼ 2.7%€2.1m▲ 1.7%€2.0m▼ 1.7%€2.0m▲ 0.2%€2.0m▲ 0.2%
Debt€1.5m▼ 11.1%€1.4m▼ 10.1%€1.2m▼ 13.6%€1.2m▲ 4.1%€1.0m▼ 19.6%
Working capital-€157,431▼ 83.6%-€83,038▲ 47.3%-€257,808▼ 210%-€418,943▼ 62.5%-€428,737▼ 2.3%
Solvency23.7%▲ 5.5pp32.6%▲ 8.8pp40.7%▲ 8.2pp38.4%▼ 2.3pp50.6%▲ 12.2pp
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 25% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.0m
Fixed assets
€2.0m =
Current assets
€34,310 ▲ 16.9%
Equity and liabilities €2.0m
Equity
€1.0m ▲ 32.0%
Debt
€1.0m ▼ 19.6%
Debt's share of the balance-sheet total falls from 61.6% to 49.4%. Equity is higher and debt is lower.
Key figures and ratios
ROE
24.3%▲
2024 · 23.6%
ROA
12.3%▲
2024 · 9.1%
Debt ≤ 1 year
€463,048▲
2024 · €448,282
Debt > 1 year
€528,461▼
2024 · €794,374
Income taxes
€18,709▼
2024 · €28,226
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €121 | - | - | - | - | - |
| Other operating charges640/8 | €2,019 | €1,322 | €1,885 | €1,660 | €1,546 | ▼ 6.9% |
| Gross operating margin9900 | €59,613 | €57,330 | €63,711 | €62,102 | €77,174 | ▲ 24.3% |
| Operating profit (loss)9901 | €57,473 | €56,007 | €61,826 | €60,442 | €75,627 | ▲ 25.1% |
| Financial income75/76B | €100,699 | €196,841 | €156,728 | €167,326 | €212,069 | ▲ 26.7% |
| Recurring financial income75 | €100,699 | €196,841 | €156,728 | €167,326 | €212,069 | ▲ 26.7% |
| Financial charges65/66B | €23,379 | €22,551 | €19,629 | €15,986 | €19,626 | ▲ 22.8% |
| Recurring financial charges65 | €23,379 | €22,551 | €19,629 | €15,986 | €19,626 | ▲ 22.8% |
| Profit (loss) for the period before taxes9903 | €134,793 | €230,297 | €198,925 | €211,782 | €268,071 | ▲ 26.6% |
| Income taxes67/77 | €17,208 | €26,124 | €24,779 | €28,226 | €18,709 | ▼ 33.7% |
| Profit (loss) for the period9904 | €117,585 | €204,173 | €174,146 | €183,555 | €249,362 | ▲ 35.9% |
| Profit (loss) for the period to be appropriated9905 | €117,585 | €204,173 | €174,146 | €183,555 | €249,362 | ▲ 35.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.0m | €2.1m | €2.0m | €2.0m | €2.0m | ▲ 0.2% |
| Fixed assets21/28 | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | = |
| Financial fixed assets28 | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | = |
| Current assets29/58 | €25,876 | €59,512 | €25,112 | €29,339 | €34,310 | ▲ 16.9% |
| Amounts receivable within one year40/41 | €22,307 | €41,102 | €3,960 | €2,634 | €17,787 | ▲ 575% |
| Trade receivables40 | €17,246 | €6,213 | €3,960 | €2,617 | €17,787 | ▲ 580% |
| Other amounts receivable41 | €5,061 | €34,889 | - | €17 | - | - |
| Cash at bank and in hand54/58 | €3,540 | €16,833 | €19,828 | €24,582 | €14,370 | ▼ 41.5% |
| Deferred charges and accrued income490/1 | €29 | €1,576 | €1,324 | €2,123 | €2,154 | ▲ 1.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.0m | €2.1m | €2.0m | €2.0m | €2.0m | ▲ 0.2% |
| Equity10/15 | €480,053 | €669,227 | €823,373 | €778,197 | €1.0m | ▲ 32.0% |
| Contributions10/11 | €100,000 | €100,000 | €100,000 | €100,000 | €100,000 | = |
| Reserves13 | €380,053 | €569,227 | €723,373 | €678,197 | €927,559 | ▲ 36.8% |
| Non-distributable reserves130/1 | €10,000 | - | - | - | - | - |
| Reserves not available under the articles1311 | €10,000 | - | - | - | - | - |
| Distributable reserves133 | €370,053 | €569,227 | €723,373 | €678,197 | €927,559 | ▲ 36.8% |
| Amounts payable17/49 | €1.5m | €1.4m | €1.2m | €1.2m | €1.0m | ▼ 19.6% |
| Amounts payable after more than one year17 | €1.3m | €1.2m | €908,916 | €794,374 | €528,461 | ▼ 33.5% |
| Financial debts170/4 | €1.3m | €1.2m | €908,916 | €794,374 | €528,461 | ▼ 33.5% |
| Amounts payable within one year42/48 | €183,307 | €142,549 | €282,920 | €448,282 | €463,048 | ▲ 3.3% |
| Current portion of amounts payable after more than one year42 | €110,527 | €111,850 | €113,188 | €114,542 | €115,913 | ▲ 1.2% |
| Trade debts44 | €3,096 | €3,406 | €4,368 | €3,916 | €22,270 | ▲ 469% |
| Suppliers440/4 | €3,096 | €3,406 | €4,368 | €3,916 | €22,270 | ▲ 469% |
| Taxes, remuneration and social security45 | €3,442 | €12,637 | €21,526 | €22,432 | €12,973 | ▼ 42.2% |
| Taxes450/3 | €3,442 | €12,637 | €21,526 | €22,432 | €12,973 | ▼ 42.2% |
| Other amounts payable47/48 | €66,242 | €14,657 | €143,838 | €307,392 | €311,892 | ▲ 1.5% |
| Accrued charges and deferred income492/3 | €10,962 | €8,032 | €6,304 | €4,886 | €11,642 | ▲ 138% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €117,585 | €204,173 | €174,146 | €183,555 | €249,362 | ▲ 35.9% |
| + Depreciation and write-downs630 | €121 | - | - | - | - | - |
| Operating cash flow (approximation) | €117,706 | €204,173 | €174,146 | €183,555 | €249,362 | ▲ 35.9% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | €13,294 | €2,995 | €4,754 | -€10,213 | ▼ 315% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Equity above €1mEq €1.0m ▲32%
8 profitable years in a row build equity to €1.0m.
01-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
11-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Equity above €500,000Eq €669,227 ▲39.4%
5 profitable years in a row build equity to €669,227.
25-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
16-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 31 days late
2019
31-12
Financial
Equity above €200,000Eq €343,301 ▲227%
2 profitable years in a row build equity to €343,301.
15-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Heist-op-den-Berg · 1 establishment unit since 2017
Ground area
545 m²
Building footprint
273 m²
Volume, LiDAR
1,688 m³
Parcel 12033A0629/00G000, Flanders · tallest building 10.3 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Storms Pharma
since 20172.270.423.570
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12033A0629/00G000 | Flanders | 544 m² | 1 · 273 m² | 10.3 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
POLY3
BE 0724.579.706
Diksmuide · Eq €1,027,543
MARBO
BE 0478.288.489
Heusden-Zolder · Eq €1,027,639
RECYCON
BE 0881.540.255
Ledegem · Eq €1,027,291
ACER TWO
BE 0894.868.946
Heist-op-den-Berg · Eq €1,028,214
HENMOR
BE 0633.922.912
Maarkedal · Eq €1,026,704
Of 24,729 companies in sector 64210 we hold annual accounts for 19,773. 12,610 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-10-2017
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID
0208:0683469918
Also
9925:BE0683469918
Registered
24-11-2023
Register as of 26 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.